A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth

Medicine & Life Sciences

• Androgen Receptors 85%
• Prostatic Neoplasms 63%
• Growth 40%
• Transcriptional Activation 22%
• Two-Hybrid System Techniques 12%
• PC-3 Cells 6%
• Doxycycline 5%
• Dimerization 5%
• Prostate-Specific Antigen 5%
• Mutagenesis 4%
• Point Mutation 4%
• Lysine 4%
• Glutamic Acid 4%
• Transfection 4%
• Plasmids 4%
• Ligands 3%
• Down-Regulation 3%
• Amino Acids 3%
• Cell Proliferation 3%
• Cell Line 2%
• In Vitro Techniques 2%
• Genes 2%
• Therapeutics 0%

Chemical Compounds

• Androgen 100%
• Doxycycline 7%
• Glutamic Acid 5%
• Oligomerization 5%
• Lysine 4%
• Dimerization 4%
• Mutation 4%
• Antigen 4%
• Acid 1%
• Molecule 1%